Frontrunner Amgen Expects US Biosimilars To ‘Shift Significantly’ With Adalimumab
Firm Prepares To Launch First Humira Biosimilar At A ‘Pivotal Time’ For The US Market
• By David Wallace
Humira biosimilars will shift the US market significantly • Source: Shutterstock 
